ESR1 and breast cancer: Indeed, in ER− tumors (not expressing the estrogen receptor and known to be the most aggressive), TRPM7 appears to be overexpressed in the most invasive areas [41], correlated to cancer metastasis and invasive BC [42], and regulates migration [41].